June Recall Roundup: SUNS Elevator Switches, Target Wipes, Gas-X, ChloraPrep And NARA Formula

BadPD source-check, June 20, 2026; source dates June 4 through June 13, 2026: five official recall lanes deserve one practical June consumer-safety ledger: SUNS residential elevator interlock switches, Target Up & Up baby wipes, Haleon Gas-X Extra Strength softgels, BD ChloraPrep/FREPP skin-prep applicators, and NARA Organics powdered infant formula.

This roundup is not a substitute for the agencies’ instructions or a medical/legal advice page. It is a source trail for households, caregivers, patients, facilities, and local accountability reporters who need to know which receipts are official, what is confirmed, what is still pending, and where the next public-record checks should point.

1. SUNS Elevator Interlock Switches

CPSC’s June 4 recall covers about 7,000 SUNS International SS6291 Solenoid Interlock switches used in residential elevators. CPSC says the affected switches can become stuck in a retracted position, allowing the exterior elevator door to remain unlocked. If the elevator is called to another floor, that can create a fall or crushing hazard with a risk of death or serious injury.

The recall applies to switches used in residential elevators produced from Aug. 20, 2024, through Nov. 6, 2025, with date codes 2431 through 2543. CPSC says consumers should stop using a residential elevator containing the affected SUNS interlock switch immediately and contact SUNS or the listed elevator installer for free professional installation of a replacement switch. SUNS has received one report of a stuck switch; CPSC says no injuries had been reported at the time of the notice.

BadPD angle: this is a home-infrastructure recall, not a gadget recall. The missing records to watch are installer outreach, homeowner notification proof, replacement scheduling backlogs, and whether real-estate, accessibility, and elder-care networks are warning people who may rely on residential elevators every day.

2. Target Up & Up Baby Wipes

FDA posted Target’s recall notice for Up & Up Fragrance Free and Fresh Cucumber Scented Baby Wipes after customer complaints of discoloration and FDA testing that identified Burkholderia cepacia complex and Burkholderia gladioli in product samples. The FDA-posted notice says contaminated products may cause serious and life-threatening infections, especially for newborns, infants, young children, and immunocompromised people.

The recalled products were sold at Target stores nationwide and online at Target.com. The recall includes multiple package sizes: fragrance-free wipes in 20, 72, 216, 800, and 1200 counts, plus Fresh Cucumber Scented wipes in 72, 216, and 800 counts. FDA’s page lists affected manufacturing-code and expiration-date ranges, and says Target told consumers to stop using the products and return them to any Target store for a full refund.

BadPD previously logged the Target wipes recall inside a June 8 receipts roundup, but the consumer-safety hook remains active because the affected products were used on the exact population most at risk from opportunistic infection. The unresolved accountability questions are buyer notification, supplier oversight, adverse-event investigation outcomes, and whether any later FDA or Target update narrows or expands the affected codes.

3. Haleon Gas-X Extra Strength Softgels

FDA posted Haleon’s June 4 nationwide recall of four lots of Gas-X Extra Strength Softgels 125 mg, in 120-count and 72-count packages, distributed to the consumer level. Haleon says the lots are being recalled because of potential contamination with a diluted propylene glycol-based coolant from a machine leak during packaging.

Haleon’s notice says ingestion of contaminated softgels may result in nausea, vomiting, abdominal pain, and diarrhea. The company says no adverse events had been reported at the time of the recall. The affected 120-count lots are TL8K, YH9X, and YH9Y, with a Nov. 30, 2028, expiration date; the affected 72-count lot is X78N, also with a Nov. 30, 2028, expiration date. Haleon says consumers who bought Gas-X Extra Strength Softgels on or after April 13, 2026, should review the lot number and stop taking the product if it matches.

BadPD angle: the accountability gap is the packaging-machine leak path. The next useful receipts would be whether retailers removed affected lots, whether return/reimbursement handling is simple, and whether Haleon or regulators disclose any root-cause or corrective-action detail beyond the recall notice.

4. BD ChloraPrep/FREPP Applicators

FDA posted BD’s June 6 company announcement for specific lots of ChloraPrep Clear 1 mL Single Sterile and FREPP Clear 1.5 mL applicators with paper lidding. The recall names lot 4032183 for ChloraPrep Clear and lot 4073005 for FREPP Clear, and says additional lots are included out of caution in BD’s customer letter. FDA’s page says the impacted lots were shipped to distributors and hospitals between March 2024 and June 2024.

The risk statement is why this belongs in a public-safety ledger. BD says contamination of skin preparation products with Aspergillus penicillioides may lead to systemic infection, sepsis, illness, or death. If the fungus is introduced during placement of an intravascular catheter, the catheter may need to be removed and replaced. Surgical-site infection may require medical or surgical intervention and long-term antifungal treatment. BD says it had not received adverse-event reports related to the recall at posting.

BadPD angle: this is a facility-action recall. The public may not have the product at home, but hospitals, distributors, outpatient procedure sites, and inventory managers need clean lot checks, destruction records, replacement handling, and adverse-event reporting. The missing receipts are facility notification, lot-level inventory pullback, and any FDA enforcement or inspection follow-up.

5. NARA Infant Formula Already Has A Full Ledger

NARA Organics is not being republished here as a new BadPD scoop because BadPD already published a full dedicated NARA formula botulism recall ledger on June 14. It stays in this roundup because the official recall is still one of the most serious June consumer-safety receipts.

FDA’s recall notice says all lots of NARA Organics powdered infant formula currently on the market were recalled because of possible Clostridium botulinum contamination risk. FDA’s outbreak advisory says officials were investigating three confirmed or suspected infant botulism illnesses in California, Pennsylvania, and Washington; all three infants were hospitalized, and FDA listed zero deaths. FDA’s page also says the investigation was in the early stages and that testing by FDA and state partners was underway. The recall notice says NARA formula had not tested positive for C. botulinum to date, so the public record still needs a testing and root-cause update.

The NARA accountability lane remains open: product-test results, manufacturing and import records, Target and NARA buyer-notification proof, timing between illness onset and recall, and any FDA/CDC update that changes the case count, product-test status, or root-cause picture.

Confirmed, Pending, Disputed

Confirmed by official records: CPSC posted the SUNS residential elevator switch recall; FDA posted the Target wipes, Gas-X, BD ChloraPrep/FREPP, and NARA infant formula recall notices; FDA posted a NARA outbreak advisory; and each notice identifies product scope, hazard, date, and remedy or facility action.

Alleged or company-stated through FDA-posted announcements: the Target wipes notice describes complaints and adverse-event reports that remain under investigation; Haleon says the Gas-X recall stems from a machine leakage during packaging; BD says the affected skin-prep products may permit fungal growth under certain environmental conditions; and NARA says the recall was issued out of caution while product testing had not yet confirmed C. botulinum in formula.

Pending records: direct buyer and facility-notification proof, retailer pullback evidence, refund/replacement friction, product-test results, adverse-event updates, root-cause findings, and enforcement or corrective-action records. None of those should be invented from the recall notices alone.

BadPD’s working rule for this cluster is simple: the public notice is the start of accountability, not the end. The recall only works when the affected product is found, removed, replaced, refunded, safely destroyed, or medically reported through the proper channel.

Source Trail

• CPSC: SUNS residential elevator interlock recall (June 4, 2026) – Official CPSC recall for about 7,000 SS6291 Solenoid Interlock switches used in residential elevators; fall/crushing hazard; repair remedy.
• FDA: Target Up & Up baby wipes recall (FDA publish date June 5, 2026; company announcement June 4, 2026) – Official FDA-posted company notice for Up & Up wipes that may be contaminated with Burkholderia cepacia complex and Burkholderia gladioli.
• FDA: Haleon Gas-X Extra Strength Softgels recall (FDA publish date June 4, 2026) – Official FDA-posted company notice for four lots of Gas-X Extra Strength Softgels over potential diluted propylene glycol-based coolant contamination.
• FDA: BD ChloraPrep/FREPP applicator recall (FDA publish date June 8, 2026; company announcement June 6, 2026) – Official FDA-posted company notice for BD ChloraPrep Clear and FREPP Clear applicators due to potential Aspergillus penicillioides contamination.
• FDA: NARA Organics infant formula recall (June 13, 2026) – Official FDA-posted company notice for all lots of NARA Organics powdered infant formula currently on the market due to potential Clostridium botulinum risk.
• FDA outbreak advisory: infant botulism and NARA formula (Current update June 13, 2026; accessed June 20, 2026) – FDA outbreak page listing three illnesses, three hospitalizations, zero deaths, and ongoing testing/traceback tied to recalled NARA formula.